Un estudio encontró que la aspirina de dosis baja no afecta el riesgo de demencia en los pacientes con diabetes
Related Posts
Risk for Existing, Incident T2D High in Children With NAFLD
TUESDAY, June 21, 2022 (HealthDay News) -- Children with nonalcoholic fatty...
Most Common Adverse Events With JYNNEOS Are Nonserious
THURSDAY, Dec. 8, 2022 (HealthDay News) -- The JYNNEOS vaccine, which is...
Pfizer to Seek FDA Approval of Boosters for Teens Ages 16 to 17
TUESDAY, Nov. 30, 2021 (HealthDay News) -- Pfizer Inc. is expected to seek...
Un nuevo fármaco reduce a la mitad las muertes entre los que tienen una COVID grave, afirma el fabricante
MARTES, 12 de abril de 2022 (HealthDay News) -- Un medicamento experimental para...